Concepts (218)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
| Kynurenine | 4 | 2020 | 140 | 1.07 | Why? |
| Tryptophan | 3 | 2020 | 218 | 0.87 | Why? |
| Pharmacogenetics | 7 | 2019 | 222 | 0.86 | Why? |
| Precision Medicine | 8 | 2019 | 1477 | 0.86 | Why? |
| Xanthurenates | 1 | 2018 | 5 | 0.77 | Why? |
| Hydroxyindoleacetic Acid | 1 | 2018 | 7 | 0.77 | Why? |
| ortho-Aminobenzoates | 1 | 2018 | 46 | 0.73 | Why? |
| Endocrine Disruptors | 1 | 2018 | 50 | 0.71 | Why? |
| Maternal-Fetal Exchange | 1 | 2018 | 209 | 0.64 | Why? |
| Birth Weight | 1 | 2018 | 250 | 0.63 | Why? |
| Maternal Exposure | 1 | 2018 | 173 | 0.63 | Why? |
| Suicide, Attempted | 2 | 2018 | 599 | 0.55 | Why? |
| Depressive Disorder, Major | 3 | 2018 | 852 | 0.49 | Why? |
| Bipolar Disorder | 2 | 2018 | 744 | 0.42 | Why? |
| Particulate Matter | 1 | 2020 | 3249 | 0.35 | Why? |
| Migraine Disorders | 3 | 2019 | 530 | 0.34 | Why? |
| Antimicrobial Cationic Peptides | 1 | 2009 | 159 | 0.34 | Why? |
| Receptors, Virus | 1 | 2020 | 5659 | 0.26 | Why? |
| Polymorphism, Genetic | 3 | 2018 | 1074 | 0.24 | Why? |
| Peptidyl-Dipeptidase A | 2 | 2020 | 9659 | 0.23 | Why? |
| Air Pollution | 1 | 2020 | 3504 | 0.23 | Why? |
| Practice Patterns, Physicians' | 2 | 2017 | 4927 | 0.22 | Why? |
| S100 Calcium Binding Protein beta Subunit | 1 | 2020 | 63 | 0.21 | Why? |
| Cluster Headache | 1 | 2019 | 24 | 0.20 | Why? |
| Euthyroid Sick Syndromes | 1 | 2021 | 150 | 0.19 | Why? |
| Exocrine Pancreatic Insufficiency | 1 | 2018 | 14 | 0.19 | Why? |
| Neurotransmitter Agents | 1 | 2019 | 57 | 0.19 | Why? |
| Schools, Pharmacy | 1 | 2019 | 61 | 0.19 | Why? |
| Pancreatitis, Chronic | 1 | 2018 | 37 | 0.19 | Why? |
| Vitamin K Deficiency | 1 | 2018 | 30 | 0.19 | Why? |
| Estradiol | 1 | 2020 | 250 | 0.19 | Why? |
| Multiple Chemical Sensitivity | 1 | 2017 | 8 | 0.18 | Why? |
| Indoleamine-Pyrrole 2,3,-Dioxygenase | 1 | 2018 | 76 | 0.18 | Why? |
| Receptors, Calcitriol | 1 | 2018 | 102 | 0.18 | Why? |
| Citalopram | 1 | 2017 | 44 | 0.18 | Why? |
| Pregnanolone | 1 | 2017 | 5 | 0.17 | Why? |
| Models, Theoretical | 1 | 2017 | 6659 | 0.17 | Why? |
| Antidepressive Agents, Second-Generation | 1 | 2017 | 41 | 0.17 | Why? |
| Dehydroepiandrosterone | 1 | 2017 | 14 | 0.17 | Why? |
| Taxoids | 1 | 2017 | 45 | 0.17 | Why? |
| Forensic Genetics | 1 | 2017 | 13 | 0.17 | Why? |
| Docosahexaenoic Acids | 1 | 2019 | 145 | 0.17 | Why? |
| Aminoisobutyric Acids | 1 | 2016 | 31 | 0.17 | Why? |
| Anti-Infective Agents | 1 | 2009 | 1766 | 0.16 | Why? |
| Antimetabolites, Antineoplastic | 1 | 2017 | 99 | 0.16 | Why? |
| Fluorouracil | 1 | 2017 | 169 | 0.16 | Why? |
| Carcinoma, Non-Small-Cell Lung | 2 | 2018 | 896 | 0.16 | Why? |
| Promoter Regions, Genetic | 1 | 2020 | 823 | 0.16 | Why? |
| Serotonin | 1 | 2017 | 137 | 0.16 | Why? |
| Transcranial Magnetic Stimulation | 1 | 2017 | 160 | 0.15 | Why? |
| Forensic Pathology | 1 | 2017 | 109 | 0.15 | Why? |
| Pregnancy | 1 | 2018 | 23879 | 0.15 | Why? |
| Digestive System Neoplasms | 1 | 2017 | 146 | 0.15 | Why? |
| Fatty Acids, Omega-3 | 1 | 2019 | 306 | 0.15 | Why? |
| Drug Monitoring | 3 | 2018 | 1408 | 0.14 | Why? |
| Drug Resistance, Neoplasm | 1 | 2018 | 447 | 0.14 | Why? |
| Fetal Blood | 1 | 2018 | 573 | 0.14 | Why? |
| Fomites | 1 | 2021 | 709 | 0.14 | Why? |
| Education, Pharmacy | 1 | 2019 | 251 | 0.14 | Why? |
| Vascular Endothelial Growth Factor A | 1 | 2018 | 604 | 0.13 | Why? |
| Programmed Cell Death 1 Receptor | 1 | 2018 | 724 | 0.13 | Why? |
| Chromatography, Liquid | 1 | 2017 | 640 | 0.13 | Why? |
| Hospital Administration | 1 | 2020 | 650 | 0.13 | Why? |
| WT1 Proteins | 1 | 2012 | 15 | 0.13 | Why? |
| Clostridium Infections | 1 | 2020 | 595 | 0.12 | Why? |
| Italy | 8 | 2021 | 38444 | 0.12 | Why? |
| Osteoporosis | 1 | 2018 | 410 | 0.12 | Why? |
| Drug Resistance, Multiple, Bacterial | 1 | 2021 | 1115 | 0.12 | Why? |
| Up-Regulation | 1 | 2020 | 2249 | 0.12 | Why? |
| Base Sequence | 1 | 2020 | 3581 | 0.12 | Why? |
| Hospitals, Teaching | 1 | 2020 | 1609 | 0.11 | Why? |
| Schools, Medical | 1 | 2019 | 793 | 0.11 | Why? |
| Clinical Protocols | 2 | 2020 | 2734 | 0.11 | Why? |
| Pilot Projects | 3 | 2020 | 5182 | 0.11 | Why? |
| Gene Silencing | 1 | 2012 | 213 | 0.11 | Why? |
| CpG Islands | 1 | 2012 | 230 | 0.11 | Why? |
| Delivery of Health Care | 2 | 2020 | 15909 | 0.11 | Why? |
| Attention Deficit Disorder with Hyperactivity | 1 | 2017 | 441 | 0.11 | Why? |
| Workflow | 2 | 2020 | 2373 | 0.11 | Why? |
| Tandem Mass Spectrometry | 1 | 2017 | 1031 | 0.11 | Why? |
| Nomograms | 1 | 2017 | 790 | 0.11 | Why? |
| Sleep Apnea, Obstructive | 1 | 2018 | 668 | 0.10 | Why? |
| Environmental Exposure | 1 | 2021 | 1558 | 0.10 | Why? |
| Breast Neoplasms | 2 | 2019 | 3633 | 0.10 | Why? |
| Anura | 1 | 2009 | 35 | 0.10 | Why? |
| Rome | 2 | 2021 | 497 | 0.09 | Why? |
| Lung Neoplasms | 2 | 2018 | 3228 | 0.09 | Why? |
| Cross Infection | 2 | 2021 | 8675 | 0.09 | Why? |
| Hematologic Neoplasms | 1 | 2021 | 2105 | 0.09 | Why? |
| Guideline Adherence | 1 | 2020 | 2309 | 0.08 | Why? |
| DNA Methylation | 1 | 2012 | 688 | 0.08 | Why? |
| Bacterial Infections | 1 | 2021 | 2229 | 0.08 | Why? |
| Hospitals | 3 | 2021 | 11793 | 0.08 | Why? |
| Humans | 37 | 2021 | 930598 | 0.08 | Why? |
| Gene Expression Regulation, Neoplastic | 1 | 2012 | 1014 | 0.08 | Why? |
| Case-Control Studies | 3 | 2021 | 17671 | 0.07 | Why? |
| Vitamin D Deficiency | 1 | 2018 | 1782 | 0.07 | Why? |
| Biomarkers | 5 | 2020 | 23361 | 0.07 | Why? |
| Female | 20 | 2021 | 380317 | 0.07 | Why? |
| International Cooperation | 1 | 2018 | 3436 | 0.07 | Why? |
| Genetic Predisposition to Disease | 1 | 2018 | 4027 | 0.07 | Why? |
| Atrial Fibrillation | 1 | 2018 | 2320 | 0.07 | Why? |
| Pneumonia, Viral | 6 | 2020 | 243684 | 0.06 | Why? |
| Vitamin D | 1 | 2018 | 2904 | 0.06 | Why? |
| Molecular Sequence Data | 1 | 2009 | 3198 | 0.06 | Why? |
| Multivariate Analysis | 3 | 2018 | 5440 | 0.06 | Why? |
| Education, Medical | 1 | 2019 | 2461 | 0.06 | Why? |
| Adult | 11 | 2020 | 244371 | 0.06 | Why? |
| Coronavirus Infections | 5 | 2020 | 253789 | 0.06 | Why? |
| Clinical Laboratory Techniques | 2 | 2020 | 23402 | 0.06 | Why? |
| Real-Time Polymerase Chain Reaction | 1 | 2021 | 11367 | 0.05 | Why? |
| Drug Interactions | 2 | 2019 | 1653 | 0.05 | Why? |
| Male | 17 | 2021 | 367725 | 0.05 | Why? |
| Antineoplastic Agents | 1 | 2017 | 3550 | 0.05 | Why? |
| Aged | 15 | 2021 | 215776 | 0.05 | Why? |
| Middle Aged | 16 | 2021 | 270681 | 0.05 | Why? |
| Signal Transduction | 1 | 2017 | 7207 | 0.05 | Why? |
| Triiodothyronine | 1 | 2021 | 201 | 0.05 | Why? |
| Tryptamines | 1 | 2019 | 29 | 0.05 | Why? |
| Antidepressive Agents, Tricyclic | 1 | 2019 | 29 | 0.05 | Why? |
| Calcitonin Gene-Related Peptide | 1 | 2019 | 52 | 0.05 | Why? |
| Quinolinic Acid | 1 | 2018 | 11 | 0.05 | Why? |
| Surface Properties | 1 | 2021 | 448 | 0.05 | Why? |
| Renal Dialysis | 1 | 2016 | 4358 | 0.05 | Why? |
| Bone Diseases, Metabolic | 1 | 2018 | 64 | 0.04 | Why? |
| Absorptiometry, Photon | 1 | 2018 | 168 | 0.04 | Why? |
| Dehydroepiandrosterone Sulfate | 1 | 2017 | 10 | 0.04 | Why? |
| Cytochrome P-450 CYP3A | 1 | 2017 | 88 | 0.04 | Why? |
| Personality Disorders | 1 | 2017 | 81 | 0.04 | Why? |
| Amino Acid Sequence | 1 | 2009 | 6049 | 0.04 | Why? |
| Genetic Markers | 1 | 2018 | 318 | 0.04 | Why? |
| Anticoagulants | 1 | 2018 | 9563 | 0.04 | Why? |
| Infant, Newborn | 1 | 2018 | 23105 | 0.04 | Why? |
| Aged, 80 and over | 7 | 2021 | 88759 | 0.04 | Why? |
| Immunoglobulin G | 1 | 2020 | 21571 | 0.04 | Why? |
| Inflammation | 1 | 2019 | 13255 | 0.04 | Why? |
| Exercise | 1 | 2016 | 6771 | 0.04 | Why? |
| Genotype | 2 | 2018 | 4697 | 0.04 | Why? |
| Bone Density | 1 | 2018 | 335 | 0.04 | Why? |
| Hand Strength | 1 | 2016 | 202 | 0.04 | Why? |
| Cross-Sectional Studies | 5 | 2021 | 53120 | 0.04 | Why? |
| Population Dynamics | 1 | 2018 | 378 | 0.03 | Why? |
| Systems Analysis | 1 | 2018 | 366 | 0.03 | Why? |
| Incidence | 3 | 2021 | 25622 | 0.03 | Why? |
| Retrospective Studies | 6 | 2021 | 105322 | 0.03 | Why? |
| Electric Impedance | 1 | 2016 | 283 | 0.03 | Why? |
| Genetic Association Studies | 1 | 2017 | 559 | 0.03 | Why? |
| Muscle Strength | 1 | 2016 | 317 | 0.03 | Why? |
| Remission Induction | 1 | 2017 | 950 | 0.03 | Why? |
| Polymorphism, Single Nucleotide | 2 | 2017 | 3607 | 0.03 | Why? |
| Pathology, Molecular | 1 | 2017 | 343 | 0.03 | Why? |
| Genetic Testing | 1 | 2017 | 395 | 0.03 | Why? |
| Multimorbidity | 1 | 2018 | 703 | 0.03 | Why? |
| Alleles | 1 | 2018 | 1557 | 0.03 | Why? |
| Body Composition | 1 | 2016 | 414 | 0.03 | Why? |
| Sex Characteristics | 1 | 2020 | 1120 | 0.03 | Why? |
| Logistic Models | 2 | 2018 | 9089 | 0.03 | Why? |
| Cell Transformation, Neoplastic | 1 | 2012 | 191 | 0.03 | Why? |
| Drug Administration Schedule | 1 | 2018 | 2324 | 0.03 | Why? |
| Leukocytes, Mononuclear | 1 | 2021 | 2115 | 0.03 | Why? |
| Switzerland | 1 | 2019 | 2738 | 0.03 | Why? |
| Administration, Oral | 1 | 2018 | 2340 | 0.03 | Why? |
| Metabolomics | 1 | 2017 | 921 | 0.03 | Why? |
| Endoscopy, Gastrointestinal | 1 | 2021 | 1545 | 0.03 | Why? |
| Single-Cell Analysis | 1 | 2021 | 2450 | 0.03 | Why? |
| Body Weight | 1 | 2016 | 1074 | 0.03 | Why? |
| Health Personnel | 1 | 2020 | 29646 | 0.02 | Why? |
| Pandemics | 7 | 2021 | 389249 | 0.02 | Why? |
| Analgesics, Opioid | 1 | 2019 | 1070 | 0.02 | Why? |
| Betacoronavirus | 4 | 2020 | 204454 | 0.02 | Why? |
| Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 1454 | 0.02 | Why? |
| Lymphocyte Count | 1 | 2020 | 4758 | 0.02 | Why? |
| Kaplan-Meier Estimate | 1 | 2018 | 4260 | 0.02 | Why? |
| Limit of Detection | 1 | 2017 | 2698 | 0.02 | Why? |
| Quality of Health Care | 1 | 2020 | 1948 | 0.02 | Why? |
| Antibodies, Viral | 1 | 2020 | 51949 | 0.02 | Why? |
| Epidemiological Monitoring | 1 | 2020 | 3493 | 0.02 | Why? |
| Prevalence | 2 | 2020 | 25773 | 0.02 | Why? |
| Schizophrenia | 1 | 2017 | 1018 | 0.02 | Why? |
| Psychotic Disorders | 1 | 2017 | 924 | 0.02 | Why? |
| Antineoplastic Combined Chemotherapy Protocols | 1 | 2017 | 1573 | 0.02 | Why? |
| Dietary Supplements | 1 | 2019 | 2251 | 0.02 | Why? |
| Patient Care Team | 1 | 2020 | 3556 | 0.02 | Why? |
| Proteomics | 1 | 2017 | 2481 | 0.02 | Why? |
| Adenocarcinoma | 1 | 2012 | 651 | 0.02 | Why? |
| Curriculum | 1 | 2019 | 3083 | 0.02 | Why? |
| Young Adult | 3 | 2020 | 93724 | 0.02 | Why? |
| Autopsy | 1 | 2017 | 3495 | 0.02 | Why? |
| Polymerase Chain Reaction | 1 | 2020 | 6740 | 0.02 | Why? |
| Risk | 1 | 2017 | 5288 | 0.02 | Why? |
| Seroepidemiologic Studies | 1 | 2020 | 10017 | 0.02 | Why? |
| Immunotherapy | 1 | 2018 | 2421 | 0.02 | Why? |
| Genomics | 1 | 2017 | 3118 | 0.02 | Why? |
| Acute Disease | 1 | 2017 | 6029 | 0.02 | Why? |
| Saliva | 1 | 2021 | 4679 | 0.02 | Why? |
| Body Mass Index | 1 | 2016 | 4306 | 0.02 | Why? |
| RNA, Viral | 2 | 2021 | 32276 | 0.02 | Why? |
| Specimen Handling | 1 | 2020 | 6190 | 0.02 | Why? |
| Chronic Disease | 1 | 2017 | 5139 | 0.01 | Why? |
| Europe | 1 | 2018 | 12702 | 0.01 | Why? |
| Surveys and Questionnaires | 2 | 2019 | 43792 | 0.01 | Why? |
| Reproducibility of Results | 1 | 2017 | 11304 | 0.01 | Why? |
| Adolescent | 2 | 2020 | 86841 | 0.01 | Why? |
| Sex Factors | 1 | 2017 | 11014 | 0.01 | Why? |
| Disease Progression | 1 | 2018 | 13580 | 0.01 | Why? |
| Animals | 1 | 2009 | 78931 | 0.01 | Why? |
| Smoking | 1 | 2012 | 3358 | 0.01 | Why? |
| Anti-Bacterial Agents | 1 | 2021 | 10083 | 0.01 | Why? |
| Biomedical Research | 1 | 2018 | 5270 | 0.01 | Why? |
| Severe Acute Respiratory Syndrome | 1 | 2020 | 12361 | 0.01 | Why? |
| Time Factors | 1 | 2020 | 31397 | 0.01 | Why? |
| Sensitivity and Specificity | 1 | 2017 | 22971 | 0.01 | Why? |
| Prospective Studies | 1 | 2018 | 43301 | 0.01 | Why? |
| Risk Assessment | 1 | 2017 | 25439 | 0.01 | Why? |
| Severity of Illness Index | 1 | 2020 | 48226 | 0.01 | Why? |
| Treatment Outcome | 1 | 2017 | 51732 | 0.01 | Why? |
| Child | 1 | 2017 | 70012 | 0.01 | Why? |
| Lung | 1 | 2012 | 31049 | 0.00 | Why? |
Simmaco's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts
(218)
Derived automatically from this person's publications.
Explore
_
Co-Authors
(129)
People in Profiles who have published with this person.
Explore
_
Similar People
(60)
People who share similar concepts with this person.
Explore
_